HHS and CMS extended postpartum coverage in New York through Medicaid and CHIP for an entire year; a minimum of 1.7 million Americans use health sharing plans, even though they lack protections; Pfizer expects pediatric syphilis drug Bicillin L-A to experience a shortage.
HHS, through CMS, on Tuesday announced New York’s continuation of comprehensive coverage following pregnancy through Medicaid and the Children’s Health Insurance Program (CHIP) for postpartum people for an entire year, according to CMS.gov. This announcement indicates vital progress in the improvement of maternal health, especially in underserved communities. New York is the 35th state authorized to provide the extended coverage by way of President Joes Biden’s American Rescue Plan and solidified by the Consolidated Appropriations Act of 2023.
The first reported national count of Americans who depend on health care sharing plans—in which people agree to pay each other’s medical bills—is higher than previously thought, reported KFF Health News. A Colorado Division of Insurance report discovered that more than 1.7 million Americans rely on sharing plans and that a lot of the plans demand members to request charity care prior to submitting their bills. It is expected that the total numbers are even higher. Sharing plans don’t ensure payment for health services and are not held against the same standards and protections as health insurance plans.
Pfizer has cautioned that supply of a drug used to treat syphilis and other bacterial infections in children could be exhausted by June’s end because it has had to prioritize forms made for adults because of a spike of syphilis infections in that population, according to Reuters. The pediatric form of the drug, Bicillin L-A, is expected to run out by the end of this quarter, according to the company. Pfizer said it is prioritizing adult dosages of Bicillin L-A that are also in shortage but stated that it does not expect them to run out.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More